中华皮肤科杂志 ›› 2014, Vol. 47 ›› Issue (10): 719-722.

• 论著 • 上一篇    下一篇

过氧化物酶增殖物激活受体β/δ在银屑病角质形成细胞中的表达

胡小平1,张伟1,陈办成1,陈史宏1,王勇强1,于波2   

  1. 1. 北京大学深圳医院
    2. 深圳市北京大学深圳医院皮肤科
  • 收稿日期:2014-01-09 修回日期:2014-03-06 发布日期:2014-10-01
  • 通讯作者: 于波 E-mail:yubomd@163.com
  • 基金资助:
    广东省自然科学基金;广东省医学科研基金;深圳市科技计划项目

Expression of peroxisome proliferator-activated receptor β/δ in psoriatic epidermal keratinocytes

  • Received:2014-01-09 Revised:2014-03-06 Published:2014-10-01
  • Supported by:
    Natural Science Foundation of Guangdong Province of China

摘要: 【摘要】 目的 探讨过氧化物酶增殖物激活受体β/δ(PPARβ/δ)在银屑病患者表皮角质形成细胞(KC)中的表达和调节因素。 方法 免疫组化方法检测PPARβ/δ在银屑病患者皮损及非皮损表皮中的表达。分离、培养银屑病患者非皮损区和皮损区的KC,以RT-PCR和Western印迹法分别检测银屑病患者皮损区和非皮损区KC中PPARβ/δ mRNA和蛋白质的表达水平。利用PPARβ/δ外源性激动剂GW501516及Ca2+刺激银屑病非皮损区KC,观察其对PPARβ/δ表达的调节影响。 结果 免疫组化显示,银屑病皮损区PPARβ/δ的表达强度显著高于正常对照组(t = 19.28,P < 0.01)和非皮损区(t = 23.26,P < 0.01)。银屑病皮损区PPARβ/δ mRNA和蛋白质的表达水平均高于正常对照组(P < 0.01)和非皮损区(P < 0.01)。10 ng/ml GW501516最大效能促进PPARβ/δ的表达(P < 0.01);1.0 mmol/L Ca2+对KC中PPARβ/δ的表达促进效应最明显(P < 0.01)。 结论 PPARβ/δ在银屑病患者皮损区表达显著升高,GW501516 和Ca2+能够促进角质形成细胞PPARβ/δ表达水平。

关键词: 银屑病, 角蛋白细胞, 过氧化物酶体增生物激活受体β/δ

Abstract: Hu Xiaoping, Zhang Wei, Chen Bancheng, Chen Shihong, Wang Yongqiang, Yu Bo. Department of Dermatology, Peking University Shenzhen Hospital, Guangdong 518036, China Corresponding author: Yu Bo, Email: yubomd@163.com 【Abstract】 Objective To measure the expression of peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in epidermal keratinocytes from patients with psoriasis, and to investigate its regulatory factors. Methods Tissue specimens were obtained from both lesional and non-lesional skin of 20 patients with psoriasis as well as from normal skin of 15 human controls. An immunohistochemical method was used to examine the expression of PPARβ/δ in these tissue specimens. Epidermal keratinocytes were isolated from these tissue specimens and subjected to a primary culture. After several passages of subculture, non-lesional psoriatic keratinocytes were stimulated with different concentrations of GW501516 (an agonist of PPARβ/δ, 0 - 100 ng/ml) and Ca2+ (0 - 3.0 mmol/L). Reverse transcription-PCR and Western blot were performed to measure the mRNA and protein expressions of PPARβ/δ in the primary keratinocytes and stimulated keratinocytes respectively. Results Immunohistochemistry showed that the expression intensity of PPARβ/δ was significantly higher in lesional psoriatic skin than in normal control skin(t = 19.28, P < 0.01) and non-lesional psoriatic skin(t = 23.26, P < 0.01). Increased mRNA and protein levels of PPARβ/δ were observed in lesional psoriatic keratinocytes as compared to normal control keratinocytes (both P < 0.01) and non-lesional psoriatic keratinocytes(both P < 0.01). Among these stimulated non-lesional psoriatic keratinocytes, those treated with GW501516 at 10 ng/ml and those with Ca2+ of 1.0 mmol/L showed the strongest expression of PPARβ/δ (both P < 0.01). Conclusions The expression of PPARβ/δ, which is higher in lesional psoriatic skin, can be enhanced by GW501516 and Ca2+ in keratinocytes.

Key words: Psoriasis, Keratinocytes, PPARβ/δ

引用本文

胡小平 张伟 陈办成 陈史宏 王勇强 于波. 过氧化物酶增殖物激活受体β/δ在银屑病角质形成细胞中的表达[J]. 中华皮肤科杂志, 2014,47(10):719-722. doi: